menaquinone-7 has been researched along with futalosine* in 1 studies
1 other study(ies) available for menaquinone-7 and futalosine
Article | Year |
---|---|
Inhibition of the futalosine pathway for menaquinone biosynthesis suppresses Chlamydia trachomatis infection.
Chlamydia trachomatis, an obligate intracellular bacterium with limited metabolic capabilities, possesses the futalosine pathway for menaquinone biosynthesis. Futalosine pathway enzymes have promise as narrow-spectrum antibiotic targets, but the activity and essentiality of chlamydial menaquinone biosynthesis have yet to be established. In this work, menaquinone-7 (MK-7) was identified as a C. trachomatis-produced quinone through liquid chromatography-tandem mass spectrometry. An immunofluorescence-based assay revealed that treatment of C. trachomatis-infected HeLa cells with the futalosine pathway inhibitor docosahexaenoic acid (DHA) reduced inclusion number, inclusion size, and infectious progeny. Supplementation with MK-7 nanoparticles rescued the effect of DHA on inclusion number, indicating that the futalosine pathway is a target of DHA in this system. These results open the door for menaquinone biosynthesis inhibitors to be pursued in antichlamydial development. Topics: Anti-Bacterial Agents; Automation; Biosynthetic Pathways; Chlamydia Infections; Chlamydia trachomatis; Docosahexaenoic Acids; HeLa Cells; Humans; Inclusion Bodies; Nanoparticles; Nucleosides; Vitamin K 2 | 2021 |